DNA X Q1 FY26 net loss widens to $3.93 million

• DNA X posted a net loss of $3.93 million for the quarter ended March 31, 2026, widening from a $961,000 loss a year earlier.
• General and administrative costs climbed to $3.62 million from $870,000, driven by $1.1 million of severance and $400,000 of bonuses tied to the asset sale.
• Discontinued operations swung to net income of $10.27 million from $1.42 million, reflecting a $15.56 million gain on the sale of the legacy phone and hotspot business.
• Cash on hand totaled $1.2 million at March 31, 2026; a May 20 financing included a $3.05 million convertible promissory note with $1.8 million in cash proceeds, expected to fund obligations through Dec. 31, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DNA X Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-024644), on May 20, 2026, and is solely responsible for the information contained therein.